A detailed history of Ratan Capital Management LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Ratan Capital Management LP holds 12,000 shares of LLY stock, worth $9.55 Million. This represents 3.0% of its overall portfolio holdings.

Number of Shares
12,000
Previous 8,000 50.0%
Holding current value
$9.55 Million
Previous $7.24 Million 46.78%
% of portfolio
3.0%
Previous 2.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $3.09 Million - $3.84 Million
4,000 Added 50.0%
12,000 $10.6 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $1.09 Million - $1.36 Million
1,500 Added 23.08%
8,000 $7.24 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $3.85 Million - $5.15 Million
6,500 New
6,500 $5.06 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ratan Capital Management LP Portfolio

Follow Ratan Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ratan Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Ratan Capital Management LP with notifications on news.